Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system

Forensic Science International

Volumn 220, Issue 1-3, 2012, Pages

  Moosmann, Bjoern ^a   Kneisel, Stefan ^a   Girreser, Ulrich ^b   Brecht, Volker ^c   Westphal, Folker ^d   Auwärter, Volker ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d State Office of Criminal Investigation Schleswig Holstein   (Germany)

Author keywords

Flash chromatography; JWH 412; Mass spectrometry; Spice; Synthetic cannabinoids

Indexed keywords

1 (5 FLUOROPENYL 1H INDOL 3 YL) (NAPHTHALEN 1 YL)METHANONE; 1 [(5 FLUOROPENTYL) 1H INDOL 3 YL] (4 METHYLNAPHTHALEN 1 YL)METHANONE; 4 FLUORONAPHTHALEN 1YL (1 PENTYLINDOL 3 YL)METHANONE; CANNABINOID; PSYCHEDELIC AGENT; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG MIXTURE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTON NUCLEAR MAGNETIC RESONANCE; SEPARATION TECHNIQUE; STRUCTURE ANALYSIS;

EID: 84862657058     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.12.010     Document Type: Article

References (11)

1. Auwärter V., Dresen S., Weinmann W., Muller M., Pütz M., Ferreiros N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?. J. Mass Spectrom. 2009, 44:832-837.
2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Thematic papers: understanding the 'Spice' phenomenon, 2009.
3. Aung M.M., Griffin G., Huffman J.W., Wu M.-J., Keel C., Yang B., Showalter V.M., Abood M.E., Martin B.R. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding. Drug Alcohol Depend. 2000, 60:133-140.
4. Huffman J.W., Mabon R., Wu M.J., Lu J., Hart R., Hurst D.P., Reggio P.H., Wiley J.L., Martin B.R. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. Bioorg. Med. Chem. 2003, 11:539-549.
5. Huffman J.W., Szklennik P.V., Almond A., Bushell K., Selley D.E., He H., Cassidy M.P., Wiley J.L., Martin B.R. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg. Med. Chem. Lett. 2005, 15:4110-4113.
6. Huffman J.W., Padgett L.W. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes. Curr. Med. Chem. 2005, 12:1395-1411.
7. A. Makriyannis, H. Deng, Cannabimimetic indole derivates, United States Patent US20080090871A1 (2007).
8. Huffman J.W., Zengin G., Wu M.-J., Lu J., Hynd G., Bushell K., Thompson A.L.S., Bushell S., Tartal C., Hurst D.P., Reggio P.H., Selley D.E., Cassidy M.P., Wiley J.L., Martin B.R. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists. Bioorg. Med. Chem. 2005, 13:89-112.
9. 35S]GTPγS binding assays. Forensic Toxicol. 2011, 29:132-141.
10. Sobolevsky T., Prasolov I., Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture post-administration urine. Forensic Sci. Int. 2010, 200:141-147.
11. V.J. Smith, Synthesis and pharmacology of N-alkyl-3-(halonaphthoyl)indoles, Ph.D. Dissertation, Clemson University, 2008.